Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
CoDAS ; 31(3): e20180111, 2019. tab, graf
Artículo en Portugués | LILACS | ID: biblio-1011929

RESUMEN

RESUMO Objetivo analisar a ocorrência do diagnóstico psiquiátrico e o uso de psicotrópicos em sujeitos com queixas vestibulares e relacionar a presença dessas condições aos resultados da vestibulometria. Método estudo quantitativo, observacional, transversal, com 131 pacientes, atendidos em um hospital universitário. Foram submetidos à anamnese, inspeção visual do meato acústico externo, provas de equilíbrio estático e dinâmico, Posturografia dinâmica foam laser e vectoeletronistagmografia computadorizada. Resultados amostra composta por 109 mulheres e 22 homens, com média de idade de 55 anos e nove meses. O tipo de tontura mais frequente foi vertigem, com presença de sintomas neurovegetativos. Observou-se expressiva porcentagem de queixa/diagnóstico psiquiátrico, bem como uso de psicotrópicos, sendo principalmente inibidores seletivos da recaptação da serotonina, seguidos dos benzodiazepínicos. Houve relação entre a presença de condições psiquiátricas e mulheres, alterações do equilíbrio estático e alterações nas posições III e VI do Teste de Organização Sensorial. Na vectoeletronistagmografia, houve relação entre a idade e a presença de nistagmo espontâneo de olhos fechados. Conclusão Constatou-se alta ocorrência de condições psiquiátricas entre pacientes com tontura, com uso de psicotrópicos maior que na população geral. Destaca-se a associação entre ansiedade/depressão e alterações nas posições de sobrecarga visual da posturografia dinâmica foam laser. No entanto, não foi observada relação entre essas condições e alterações nas provas da vectoeletronistagmografia.


ABSTRACT Purpose to analyze the occurrence of psychiatric diagnosis and the use of psychotropics medications in subjects with vestibular complaints and to relate the presence of these conditions to the results of vestibulometry. Methods quantitative, observational, cross-sectional study with 131 patients, treated in a university hospital. They were submitted to anamnesis, visual inspection of the external ear canal, static and dynamic balance tests, Foam laser dynamic posturography and Computerized Vectoelectronystagmography. Results sample composed of 109 women and 22 men, with average age of 55 years and nine months. The most common type of dizziness was vertigo, with the presence of neurovegetative signals. A significant percentage of psychiatric complaint/diagnosis was observed, as well as the use of psychotropic medications, mainly serotonin uptake inhibitors, followed by benzodiazepines. There was a relation between the presence of psychiatric complaints with the female gender, alterations of the static balance and alterations in the Sensorial Organization Test positions III and VI. In the Vectoelectronystagmography, there was a relation between age and the presence of spontaneous nystagmus. Conclusion There was a high occurrence of psychiatric complaint/diagnosis among patients with dizziness, with use of psychotropic medications substantially greater than the general population. The evaluation of postural balance revealed an association between anxiety/depression and alterations visual overload positions in the foam laser dynamic posturography. However, no relationship was found between these conditions and alterations in the Vectoelectronystagmography tests.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Adulto Joven , Psicotrópicos/efectos adversos , Pruebas de Función Vestibular/métodos , Vértigo/inducido químicamente , Trastornos del Humor/tratamiento farmacológico , Mareo/inducido químicamente , Equilibrio Postural/efectos de los fármacos , Psicotrópicos/clasificación , Estudios Retrospectivos , Trastornos del Humor/complicaciones
2.
Rev. Soc. Bras. Med. Trop ; 50(5): 646-651, Sept.-Oct. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-897011

RESUMEN

Abstract INTRODUCTION: A total of 771 cases of multidrug-resistant tuberculosis (MDR-TB) were reported in Brazil in 2014. Treatment of MDR-TB with aminoglycosides can produce serious side effects such as permanent and irreversible hearing loss, which occurs in 5-64% of cases, and severely compromise patient quality of life. The goal of this research was to evaluate auditory and vestibular side effects in patients treated for MDR-TB and to identify associations between these complaints and the type of aminoglycoside used. METHODS: We performed a retrospective review of 599 medical records from patients with MDR-TB who were treated at the Hélio Fraga/Fiocruz Reference Center between 2006 and 2010. Cases without auditory or vestibular complaints and patients who were not treated with aminoglycoside drugs were excluded from the study. RESULTS: Of 164 eligible cases, 55 (33.5%) reported an auditory or vestibular complaint and medication was subsequently suspended, although hearing damage was not confirmed in all cases. Audiometric testing confirmed hearing loss in 11 (21.7%) of 12 cases submitted for evaluation. Hearing loss related to ototoxicity was confirmed in 15 (62.5%) cases. Tinnitus was significantly associated with the use of amikacin and streptomycin. CONCLUSIONS: Evaluations of ototoxicity symptoms were not usually reported in the routine care of patients with MDR-TB. Complaints of tinnitus were associated with amikacin and streptomycin use. These results require confirmation in future studies.


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Adulto , Adulto Joven , Audiometría/métodos , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Aminoglicósidos/efectos adversos , Pérdida Auditiva/diagnóstico , Pérdida Auditiva/inducido químicamente , Antibacterianos/efectos adversos , Factores de Tiempo , Acúfeno/diagnóstico , Acúfeno/inducido químicamente , Amicacina/efectos adversos , Estreptomicina/efectos adversos , Enfermedades Vestibulares/diagnóstico , Enfermedades Vestibulares/inducido químicamente , Factores Sexuales , Estudios Retrospectivos , Factores de Edad , Tuberculosis Resistente a Múltiples Medicamentos/complicaciones , Mareo/diagnóstico , Mareo/inducido químicamente , Persona de Mediana Edad
4.
Rev. Inst. Med. Trop. Säo Paulo ; 56(5): 439-442, Sep-Oct/2014. graf
Artículo en Inglés | LILACS | ID: lil-722321

RESUMEN

Introduction: Pentavalent antimonials are the first drug of choice in the treatment of tegumentary leishmaniasis. Data on ototoxicity related with such drugs is scarcely available in literature, leading us to develop a study on cochleovestibular functions. Case Report: A case of a tegumentary leishmaniasis patient, a 78-year-old man who presented a substantial increase in auditory threshold with tinnitus and severe rotatory dizziness during the treatment with meglumine antimoniate, is reported. These symptoms worsened in two weeks after treatment was interrupted. Conclusion: Dizziness and tinnitus had already been related to meglumine antimoniate. However, this is the first well documented case of cochlear-vestibular toxicity related to meglumine antimoniate.


Introdução: Antimoniais pentavalentes são os fármacos de primeira escolha no tratamento da leishmaniose tegumentar. Dados de ototoxicidade relacionados a tais fármacos são escassos na literatura, o que nos levou a desenvolver um estudo de funções cócleo-vestibulares. Relato de caso: Relatamos caso de paciente masculino de 78 anos com leishmaniose tegumentar, que apresentou aumento significativo dos limiares auditivos com zumbido e tontura rotatória grave durante o tratamento com antimoniato de meglumina. Os sintomas pioraram até duas semanas após a interrupção do tratamento. Conclusão: Tontura e zumbido já tinham sido associados ao antimoniato de meglumina. Entretanto, este é o primeiro caso bem documentado de toxicidade cócleo-vestibular relacionado ao antimoniato de meglumina.


Asunto(s)
Anciano , Humanos , Masculino , Antiprotozoarios/efectos adversos , Umbral Auditivo/efectos de los fármacos , Mareo/inducido químicamente , Meglumina/efectos adversos , Compuestos Organometálicos/efectos adversos , Acúfeno/inducido químicamente , Audiometría de Tonos Puros , Leishmaniasis Cutánea/tratamiento farmacológico , Índice de Severidad de la Enfermedad
6.
Indian Pediatr ; 2008 Nov; 45(11): 899-904
Artículo en Inglés | IMSEAR | ID: sea-6749

RESUMEN

OBJECTIVE: To compare a combined dose of ketamine and midazolam versus ketamine alone in the sedation of children requiring lumbar puncture. STUDY DESIGN: A randomized, controlled study, conducted between January 2004 and December 2006. SETTING: The Pediatric Emergency Department (PED) at Ankara Training and Research Hospital, Turkey. PARTICIPANTS: A random sample of 99 children (59 boys, 40 girls) aged 2-14 years (mean age 6.5+/-3.7) undergoing lumbar puncture. INTERVENTION: Participants were randomized to receive intravenous (IV) ketamine only (1 mg/kg; IVK) (n=51) or ketamine plus midazolam (1 mg/kg ketamine+0.1 mg/kg midazolam; IVKM) (n=48). MAIN OUTCOME MEASURES: The mean time to sedation and adverse events. RESULTS: The mean time to sedation was significantly shorter in the IVKM group than the IVK group (2.6+/-1.1 and 3.4+/-1.7 min, respectively; P=0.01). The parental satisfaction was significantly higher in the IVKM group (P=0.001). Also the fasting time and recovery time did not differ between groups, nor was there a significant difference in nausea/vomiting between groups. Nightmares or crying spells were more common in the IVK group than in the IVKM group (P=0.04). CONCLUSIONS: We conclude that adding midazolam to ketamine did not increase the frequency of adverse events and that the combined sedative was superior to ketamine alone in terms of speed of sedation and parental satisfaction.


Asunto(s)
Adolescente , Anestésicos Disociativos/administración & dosificación , Anestésicos Intravenosos/administración & dosificación , Niño , Intervalos de Confianza , Mareo/inducido químicamente , Quimioterapia Combinada , Femenino , Humanos , Ketamina/administración & dosificación , Masculino , Midazolam/administración & dosificación , Náusea/inducido químicamente , Oportunidad Relativa , Consumo de Oxígeno , Dolor/tratamiento farmacológico , Dolor Postoperatorio/tratamiento farmacológico , Satisfacción del Paciente , Vómitos/inducido químicamente , Adulto Joven
7.
Rev. Soc. Bras. Med. Trop ; 41(1): 65-69, jan.-fev. 2008. tab
Artículo en Portugués | LILACS | ID: lil-478897

RESUMEN

Ototoxicidade e terapia anti-retroviral parecem estar associadas. O objetivo desse estudo foi avaliar essa possível correlação. Foram avaliados 779 prontuários médicos de pacientes infectados pelo HIV e regularmente acompanhados, sendo 162 tratados com terapia anti-retroviral e 122 não tratados (controle). Pacientes em tratamento eram mais velhos (média 42 anos), com maior tempo de confirmação sorológica (80 meses) e com menor carga viral (p=0,00). CD4+ foi semelhante entre os grupos (P=0,60). No grupo tratado, três (1,8 por cento) casos de perda auditiva idiopática e dois (1,3 por cento) de perda auditiva relacionada a otosclerose foram observadas e ambas iniciadas após terapia anti-retroviral. Nenhuma diferença estatística relacionada à perda auditiva idiopática foi encontrada entre os grupos. Enquanto estudos descritivos consideram possível ototoxidade associada à terapia anti-retroviral, esse possível efeito adverso não foi relacionado à terapia anti-retroviral neste estudo. Contrariamente, otosclerose poderia estar correlacionada à terapia anti-retroviral. Este assunto merece ser estudado.


Ototoxicity and antiretroviral therapy seem to be associated. The aim of this study was to evaluate this possible correlation. Evaluations were carried out on 779 medical records from HIV-infected patients who were being regularly followed up, of whom 162 were being treated with antiretroviral therapy and 122 were untreated (controls). The patients undergoing treatment were older (mean: 42 years), had had serological confirmation for longer times (80 months) and had smaller viral loads (P = 0.00). CD4+ was similar between the groups (P = 0.60). In the treated group, three cases (1.8 percent) of idiopathic hearing loss and two (1.3 percent) of otosclerosis-related hearing loss were observed, which both started after antiretroviral therapy. No statistical difference relating to idiopathic hearing loss was found between the groups. While descriptive studies consider possible ototoxicity associated with antiretroviral therapy, this possible adverse effect was not related to the antiretroviral therapy in this study. Conversely, otosclerosis might have been correlated with antiretroviral therapy. This issue deserves to be studied.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Fármacos Anti-VIH/efectos adversos , Mareo/inducido químicamente , Infecciones por VIH/tratamiento farmacológico , Pérdida Auditiva/inducido químicamente , Acúfeno/inducido químicamente , Fármacos Anti-VIH/uso terapéutico , Estudios de Casos y Controles , /virología , Carga Viral
8.
Rev. bras. otorrinolaringol ; 72(3): 350-354, maio-jun. 2006. tab
Artículo en Portugués, Inglés | LILACS | ID: lil-436286

RESUMEN

OBJETIVO: Correlacionar o uso de contraceptivo hormonal oral com possíveis alterações auditivas e vestibulares. MÉTODOS: Aplicou-se anamnese, teste audiométrico e teste vestibular em 60 mulheres entre 14 e 35 anos, sendo que 30 mulheres faziam uso do método contraceptivo hormonal oral composto por estrógeno e progesterona (grupo de risco), por um período igual ou superior a 6 meses, sem queixas auditivas e vestibulares anteriores ao uso do mesmo; e 30 mulheres que nunca fizeram uso desses hormônios (grupo controle), sem queixas auditivas e vestibulares. A anamnese foi utilizada como critério de seleção da amostra. RESULTADOS: Com base nos achados otoneurológicos através de uma pesquisa quantitativa, pode-se verificar uma prevalência da Síndrome Vestibular Periférica Irritativa e de zumbidos no grupo de risco, sem alterações audiométricas. CONCLUSÃO: O uso do método contraceptivo hormonal oral pode ocasionar alterações funcionais na orelha interna, principalmente zumbido e Síndrome Vestibular Periférica Irritativa no grupo de risco, mas não evidenciou alterações de limiares auditivos.


AIM: To co-relate the use of hormonal contraceptives with positive Auditory and Vestibular alterations. METHODS: medical history taking, audiometric test and vestibular test was applied to 60 women between the ages of 14 and 35 years old, and 30 of these women are on oral hormonal contraceptive consisting of Estrogen and Progesterone (risk group), for 6 months or more, that had no Auditory or Vestibular complaints prior to the usage of hormones; and 30 women that had never used these hormones (control group), with no Auditory or Vestibular complaints. Medical history was used to select the sample. RESULTS: Based on otoneurological findings, through quantitative research, we could see the prevailing Irritatative Peripheral Vestibular Syndrome and tinnitus in the risk group, without audiometric alterations. CONCLUSION: The use of oral contraceptives can provoke functional alterations in the inner ear, specially tinnitus and Irritative Peripheral Vestibular Syndrome in the risk group; but auditory threshold alterations were not evident.


Asunto(s)
Humanos , Femenino , Adolescente , Adulto , Anticonceptivos Hormonales Orales/efectos adversos , Mareo/inducido químicamente , Acúfeno/inducido químicamente , Audiometría , Estudios de Casos y Controles , Factores de Riesgo , Mareo/diagnóstico , Pruebas de Función Vestibular , Acúfeno/diagnóstico
9.
J Indian Med Assoc ; 2004 Sep; 102(9): 525-7
Artículo en Inglés | IMSEAR | ID: sea-97051

RESUMEN

The objective of the study was to assess the efficacy, safety and tolerability of a fixed dose combination of telmisartan 40 mg and hydrochlorothiazide 12.5 mg in adult Indian patients with mild to moderate hypertension. A prospective, multicentric, open-label, non-comparative, phase IV study was conducted. A total of 353 patients of either sex, between 18- 65 years of age with supine blood pressure (BP) levels of systolic BP (SBP) of 140-200 mmHg and diastolic BP (DBP) of 95-114 mmHg were included. After a placebo run-in period of 2 weeks, each patient received a fixed dose combination of telmisartan/hydrochlorothiazide (40mg/12.5mg) once daily, for 8 weeks. Supine BP was assessed at the end of every 2 weeks. Tolerability and safety were assessed by physical examination, laboratory parameters and evaluation of adverse events. A total of 339 patients completed the study with 14 drop-out cases because of loss to follow-up. There was a significant fall (p<0.05) in both the SBP and DBP starting from the second week as compared to the baseline. Mean SBP had a significant reduction of 23.55 mmHg (15.0%) and 27.79 mmHg (18%) at the end of 6th and 8th week respectively, compared to baseline values. Mean DBP had also had a significant reduction of 12.51 mmHg (12.6%) and 15.17 mmHg (15.3%) at the end of 6th and 8th week respectively, compared to baseline values. This combination was well tolerated with only 3.9% of the total cases reporting mild adverse events like fatigue, dizziness, nausea, diarrhoea etc. The laboratory values were within normal limits. Fixed dose combination of telmisartan/hydrochlorothiazide (40 mg/12.5 mg) once daily has a significant therapeutic effect and a good tolerability profile in adult Indian patients with mild to moderate hypertension.


Asunto(s)
Adolescente , Adulto , Bloqueadores del Receptor Tipo 1 de Angiotensina II/administración & dosificación , Antihipertensivos/administración & dosificación , Bencimidazoles/administración & dosificación , Benzoatos/administración & dosificación , Mareo/inducido químicamente , Quimioterapia Combinada , Fatiga/inducido químicamente , Femenino , Humanos , Hidroclorotiazida/administración & dosificación , Hipertensión/tratamiento farmacológico , India , Masculino , Persona de Mediana Edad , Náusea/inducido químicamente , Estudios Prospectivos , Resultado del Tratamiento
10.
Indian J Med Sci ; 2002 Jul; 56(7): 315-20
Artículo en Inglés | IMSEAR | ID: sea-68058

RESUMEN

The aim of our study was to evaluate and compare the therapeutic efficacy & safety profile of three different antituberculous regimens for pulmonary tuberculosis. The study sample size included 90 newly diagnosed, sputum positive patients of pulmonary. tuberculosis. 30 each from different groups. The parameters studied were, therapeutic efficacy included weight gain, cough, sputum examination and safety profile: nausea, vomiting, anorexia, gastritis, hepatitis, jaundice diarrhoea, rashes, dizziness, tingling & numbness, flu like symptoms & joint aches. Group-I showed statistically significant weight gain when compared to Group-II. Improvement in cough and conversion to smear negative were seen in 100% of patients in Group-I, 83.3% of patients in Group-II and 93.3% of patients in Group-III. Therapeutic efficacy was highest with Group I regimen, followed by Group III and Group II which was least efficacious. Group II also registered; the maximum cost and highest incidence of adverse effects.


Asunto(s)
Adulto , Antituberculosos/administración & dosificación , Mareo/inducido químicamente , Quimioterapia Combinada , Etambutol/administración & dosificación , Femenino , Estudios de Seguimiento , Gastritis/inducido químicamente , Humanos , Hipoestesia/inducido químicamente , Isoniazida/administración & dosificación , Masculino , Náusea/inducido químicamente , Pirazinamida/administración & dosificación , Rifampin/administración & dosificación , Estreptomicina/administración & dosificación , Resultado del Tratamiento , Tuberculosis Pulmonar/complicaciones
11.
Arq. bras. med ; 67(2): 149-51, mar.-abr. 1993. tab
Artículo en Portugués | LILACS | ID: lil-123626

RESUMEN

O uso do nimesulide näo provocou a ocorrência de sintomas e sinais de disfunçäo vestibular em pacientes com doenças reumáticas, ao contrário do que se verificou com o uso de diclofenaco sódico, naproxeno sódico e ibuprofeno; a diferença entre diclofenaco e nimesulide, quanto à ocorrência de sintomas e sinais vestibulares neste grupo de pacientes, foi estatisticamente significante


Asunto(s)
Humanos , Masculino , Femenino , Antiinflamatorios no Esteroideos/farmacología , Diclofenaco/efectos adversos , Enfermedades Reumáticas/fisiopatología , Oído Interno/efectos de los fármacos , Naproxeno/efectos adversos , Artritis Reumatoide/fisiopatología , Depresores del Sistema Nervioso Central/farmacología , Mareo/inducido químicamente , Ibuprofeno/efectos adversos
12.
Indian J Lepr ; 1988 Jan; 60(1): 84-6
Artículo en Inglés | IMSEAR | ID: sea-54950

RESUMEN

Two cases of 'flu' syndrome on once monthly rifampicin are reported. The symptoms were reproduced in one patient with the next supervised dose. In the second patient they did not recur probably because she was receiving systemic steroids for left ulnar neuritis.


Asunto(s)
Adulto , Mareo/inducido químicamente , Esquema de Medicación , Femenino , Fiebre/inducido químicamente , Humanos , Lepra Dimorfa/tratamiento farmacológico , Rifampin/administración & dosificación , Tiritona , Síndrome
13.
Southeast Asian J Trop Med Public Health ; 1979 Dec; 10(4): 604-9
Artículo en Inglés | IMSEAR | ID: sea-36063

RESUMEN

The animal studies in mice resulted as follows. Long-term exposure to NO2 at or above 0.5 ppm affected primarily the respiratory organs. The pulmonary effect of NO was slighter than NO2. Nitrosylhemoglobin formation in vivo was much smaller than in vitro strong affinity of NO with hemoglobin. The components other than O3 contained in the photochemically formed oxidant mixtures enhanced the effect of O3 alone. Symptoms of the patients seriously injured by photochemical smog in Japan suggested the different type in quality from the Los Angeles-type smog.


Asunto(s)
Contaminación del Aire , Animales , Mareo/inducido químicamente , Oftalmopatías/inducido químicamente , Glutatión/metabolismo , Hemoglobinas/metabolismo , Humanos , Japón , Pulmón/metabolismo , Ratones , Náusea/inducido químicamente , Óxido Nítrico/sangre , Dióxido de Nitrógeno/farmacología , Sistema Respiratorio/efectos de los fármacos , Enfermedades Respiratorias/inducido químicamente , Esmog
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA